RICO – Pharmaceutical marketing

Where (1) a federal jury found that a defendant engaged in a RICO enterprise that
committed mail and wire fraud by fraudulently marketing the drug Neurontin for off-label conditions such as bipolar disorder, neuropathic pain and migraine, (2) the jury award was trebled to $142,089,276 and (3) the plaintiffs, who spent about $200 million on Neurontin ...